Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05774002 · ClinicalTrials.gov registry record · NA

Psychological Assessment of Scoliosis Patients Undergoing Surgical Management

A NA study of Mental Health and Adolescent Idiopathic Scoliosis (AIS), sponsored by Montefiore Medical Center.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT05774002: Recruiting NA study of Mental Health and Adolescent Idiopathic Scoliosis (AIS), sponsored by Montefiore Medical Center.

NCT05774002 is a NA study of Mental Health and Adolescent Idiopathic Scoliosis (AIS) that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 120 participants, below the 10,181-participant average among 62 other Mental Health trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05774002, a NA study of Mental Health and Adolescent Idiopathic Scoliosis (AIS), is actively recruiting participants, sponsored by Montefiore Medical Center.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Working in partnership with Montefiore-Einstein's Department of Translational Psychiatry, the investigators have designed a prospective randomized clinical trial (2:1) study for 45 Adolescent Idiopathic Scoliosis (AIS) patients, 10-19 years of age. This protocol includes a baseline assessment of mental health, pain, and function in AIS patients utilizing validated patient reported outcome (PRO) measures. The investigators will implement and test a structured perioperative psychological intervention program, based on the Aim to Decrease Anxiety and Pain Treatment (ADAPT), which was developed based on evidence-based cognitive behavioral therapy (CBT) protocols for the management of pediatric pain and childhood anxiety disorders

Primary Outcome

Assessment of changes in anxiety, preoperatively to postoperatively, will be assessed using the Beck Anxiety Inventory (BAI). The BAI is a 21-item, self-report tool used to assess anxiety severity over the prior week. Participants are asked to rate their anxiety symptoms using a scale of 0-3 which correlate to "Not at all," "Mildly," "Moderately," or "Severely," respectively. Scores are then totaled yielding an overall range of 0-63. Scores of 0-7 are indicative of low anxiety; 8-15 mild anxiety

Interventions

  • BEHAVIORAL Aims to Decrease Anxiety and Pain Treatment (ADAPT)

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2023-10-06
Est. Completion 2028-10
Phase NA
Montefiore Medical Center

345 total trials

What NCT05774002 shows while recruiting

NCT05774002 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 10,181-participant average among 62 other Mental Health trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Mental Health appearing as the primary indexed condition, and to 1 intervention - of which Aims to Decrease Anxiety and Pain Treatment (ADAPT) is the first listed.

NCT05774002 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05774002 about?

NCT05774002 is a clinical study titled "Psychological Assessment of Scoliosis Patients Undergoing Surgical Management". Working in partnership with Montefiore-Einstein's Department of Translational Psychiatry, the investigators have designed a prospective randomized clinical trial (2:1) study for 45 Adolescent Idiopathic Scoliosis (AIS) patients, 10-19 years of age. This protocol includes a baseline assessment of men...

What is the current status of trial NCT05774002?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-10-06. Estimated completion is 2028-10.

What conditions does trial NCT05774002 study?

This clinical trial studies the following conditions: Mental Health, Adolescent Idiopathic Scoliosis (AIS).

What interventions are being tested in trial NCT05774002?

The interventions under investigation include: Aims to Decrease Anxiety and Pain Treatment (ADAPT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05774002?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05774002 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05774002's enrollment target sits among peer trials

120 42nd of 62 higher than 19 of 62 other Mental Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05774002, the US trial registry maintained by the National Library of Medicine. NCT05774002 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.